- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04456751
Is Redo Pediatric Cardiac Surgery a Risk Factor for Transfusion?
August 25, 2020 updated by: Denis SCHMARTZ, Brugmann University Hospital
Is a Reintervention for Pediatric Cardiac Surgery Associated With Higher Blood Transfusion Requirements ?
In pediatric cardiac surgery, transfusion requirements are associated with age, development status, pathology, type of surgical intervention and extracorporeal bypass.
In adult cardiac surgery, reinterventions (redo)are clearly linked to higher transfusion rates.
The investigators want to study if this association is also true in pediatric cardiac surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Whereas in adult cardiac surgery, redo-interventions are clearly linked to a higher transfusion rate, this is not really known in paediatric cardiac surgery.
In this retrospective study, the investigators will analyse our database for paediatric cardiac surgery patients aged 0-16 years and operated between 2002 and 2017.
Patients with a single cardiac surgery will be compared to patients with a second cardiac operation under extracorporeal bypass.
The investigators will test the variables for normal distribution using a Shapiro-Wilk test.
Non normal distributed variables will be compared by a non-parametric test (Mann Whitney U), frequency analysis will be done by a Chi-Square test.
A univariate analysis will determine predicting factors for transfusion.
Factors with a P value < 0.1 will be analysed by a multivariate analysis to determine independent factors for transfusion.
Odds with 95% confidence intervals will be calculated.
A P value < 0.05 will be considered statistically significant.
Study Type
Observational
Enrollment (Actual)
2439
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussels, Belgium, 1020
- Hôpital Universitaire des Enfants Reine Fabiola
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 16 years (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients between 0 and 16 years undergoing cardiac surgery with cardiopulmonary bypass in our institution.
We will exclude Jehovah's witness patient as they refuse a transfusion.
Description
Inclusion Criteria:
- Patients between 0 and 16 years
- Cardiac surgery with cardiopulmonary bypass
Exclusion Criteria:
- Jehova's witness
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
No redo op
Patients with a single cardiac operation under extracorporeal bypass
|
|
|
Redo op
Patients with a redo cardiac operation under extracorporeal bypass
|
Patients with a redo operation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transfusion of packed red cells (mL/kg)
Time Frame: Day of operation up to 5 days postop
|
Transfusion requirements will be measured as volume of packed red cells given as mL packed red cells/kg of body weight
|
Day of operation up to 5 days postop
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 2, 2020
Primary Completion (Actual)
August 15, 2020
Study Completion (Actual)
August 15, 2020
Study Registration Dates
First Submitted
June 25, 2020
First Submitted That Met QC Criteria
June 30, 2020
First Posted (Actual)
July 2, 2020
Study Record Updates
Last Update Posted (Actual)
August 26, 2020
Last Update Submitted That Met QC Criteria
August 25, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- CHUB_redoped
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cardiac Surgery
-
Brugmann University HospitalQueen Fabiola Children's University HospitalCompletedPediatric Cardiac SurgeryBelgium
-
Seoul National University HospitalCompletedPediatric Cardiac SurgeryKorea, Republic of
-
Senthil SadhasivamEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingPediatric Cardiac SurgeryUnited States
-
Brugmann University HospitalCompletedPediatric Cardiac Surgery | GenderBelgium
-
Wake Forest University Health SciencesCompletedPediatric Cardiac Surgery | Complication of Extracorporeal CirculationUnited States
-
Cukurova UniversityCompletedSIRS | Pediatric Cardiac SurgeryTurkey
-
Driscoll Children's HospitalNot yet recruitingEducation | Pediatric Cardiac Surgery | Patient Education | Cardiology | Outpatient Clinics, Hospital | Shared Decision-makingUnited States
-
China National Center for Cardiovascular DiseasesCompletedPediatric Cardiac Surgery | Mitral Regurgitation (MR)China
-
Emory UniversityCompleted
-
Postgraduate Institute of Medical Education and...CompletedPediatric Cardiac Surgery | Intraoperative Awareness | Automated Drug DeliveryIndia
Clinical Trials on Redo op
-
Institut für Pharmakologie und Präventive MedizinEdwards LifesciencesRecruitingProsthesis Failure | Structural Valve Degeneration | Structural Valve Deterioration | Prosthetic Valve Malfunction | Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) FailureAustria, Italy, Spain, Canada, France, Switzerland, Israel, Poland, Germany, Netherlands, Portugal
-
Cancer Institute and Hospital, Chinese Academy...CompletedColo-rectal Cancer | Anastomosis, Leaking
-
Shanghai Zhongshan HospitalRecruiting
-
Seoul National University HospitalCompletedNeurogenic Bladder | Tethered Spinal Cord Syndrome
-
Meshalkin Research Institute of Pathology of CirculationUnknownAtrial Fibrillation | Arterial HypertensionRussian Federation, United States
-
International Medical UniversityKotra Pharma (M) Sdn BhdCompletedCancer of Breast | Cancer ColonMalaysia
-
Inje UniversityCompleted
-
Concentra AI, incRecruitingTotal Hip Replacement | Total Knee ReplacementUnited States
-
Instituto Dante Pazzanese de CardiologiaEdwards LifesciencesCompletedMitral Prosthetic Valve Stenosis and RegurgitationBrazil
-
Molnlycke Health Care ABCompleted